Logo image of ISRG

INTUITIVE SURGICAL INC (ISRG) Stock Price, Forecast & Analysis

USA - NASDAQ:ISRG - US46120E6023 - Common Stock

565.51 USD
-6.94 (-1.21%)
Last: 11/13/2025, 8:00:02 PM
565.62 USD
+0.11 (+0.02%)
Pre-Market: 11/14/2025, 4:01:17 AM

ISRG Key Statistics, Chart & Performance

Key Statistics
Market Cap202.72B
Revenue(TTM)9.61B
Net Income(TTM)2.75B
Shares358.48M
Float356.22M
52 Week High616
52 Week Low425
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)8.61
PE65.68
Fwd PE57.17
Earnings (Next)01-21 2026-01-21/amc
IPO2000-06-13
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment


ISRG short term performance overview.The bars show the price performance of ISRG in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 10 20 30

ISRG long term performance overview.The bars show the price performance of ISRG in the last 1, 2 and 3 years. 1 year 2 years 3 years 20 40 60 80 100

The current stock price of ISRG is 565.51 USD. In the past month the price increased by 30.12%. In the past year, price increased by 7.18%.

INTUITIVE SURGICAL INC / ISRG Daily stock chart

ISRG Latest News, Press Relases and Analysis

ISRG Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 25.9 224.97B
BSX BOSTON SCIENTIFIC CORP 35.59 155.55B
SYK STRYKER CORP 28.35 142.76B
IDXX IDEXX LABORATORIES INC 55.63 56.12B
BDX BECTON DICKINSON AND CO 13.39 55.33B
EW EDWARDS LIFESCIENCES CORP 33.51 50.56B
RMD RESMED INC 25.47 36.79B
GEHC GE HEALTHCARE TECHNOLOGY 16.12 33.77B
PODD INSULET CORP 72.79 23.42B
DXCM DEXCOM INC 32.11 23.42B
ZBH ZIMMER BIOMET HOLDINGS INC 11.2 17.94B
HOLX HOLOGIC INC 17.39 16.52B

About ISRG

Company Profile

ISRG logo image Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. The company is headquartered in Sunnyvale, California and currently employs 15,638 full-time employees. The company went IPO on 2000-06-13. The firm specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.

Company Info

INTUITIVE SURGICAL INC

1020 Kifer Road

Sunnyvale CALIFORNIA 94086 US

CEO: Gary S. Guthart

Employees: 15638

ISRG Company Website

ISRG Investor Relations

Phone: 14085232100

INTUITIVE SURGICAL INC / ISRG FAQ

Can you describe the business of INTUITIVE SURGICAL INC?

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. The company is headquartered in Sunnyvale, California and currently employs 15,638 full-time employees. The company went IPO on 2000-06-13. The firm specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.


Can you provide the latest stock price for INTUITIVE SURGICAL INC?

The current stock price of ISRG is 565.51 USD. The price decreased by -1.21% in the last trading session.


Does INTUITIVE SURGICAL INC pay dividends?

ISRG does not pay a dividend.


How is the ChartMill rating for INTUITIVE SURGICAL INC?

ISRG has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 7 out of 10.


What is INTUITIVE SURGICAL INC worth?

INTUITIVE SURGICAL INC (ISRG) has a market capitalization of 202.72B USD. This makes ISRG a Mega Cap stock.


What is the next earnings date for ISRG stock?

INTUITIVE SURGICAL INC (ISRG) will report earnings on 2026-01-21, after the market close.


What is the Short Interest ratio of INTUITIVE SURGICAL INC (ISRG) stock?

The outstanding short interest for INTUITIVE SURGICAL INC (ISRG) is 2.07% of its float.


ISRG Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to ISRG. When comparing the yearly performance of all stocks, ISRG is one of the better performing stocks in the market, outperforming 75.77% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

ISRG Fundamental Analysis

ChartMill assigns a fundamental rating of 7 / 10 to ISRG. ISRG scores excellent points on both the profitability and health parts. This is a solid base for a good stock.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ISRG Financial Highlights

Over the last trailing twelve months ISRG reported a non-GAAP Earnings per Share(EPS) of 8.61. The EPS increased by 28.12% compared to the year before.


Industry RankSector Rank
PM (TTM) 28.58%
ROA 14.19%
ROE 16.12%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%30.43%
Sales Q2Q%22.91%
EPS 1Y (TTM)28.12%
Revenue 1Y (TTM)22.18%

ISRG Forecast & Estimates

41 analysts have analysed ISRG and the average price target is 608.71 USD. This implies a price increase of 7.64% is expected in the next year compared to the current price of 565.51.

For the next year, analysts expect an EPS growth of 19.93% and a revenue growth 21.17% for ISRG


Analysts
Analysts78.54
Price Target608.71 (7.64%)
EPS Next Y19.93%
Revenue Next Year21.17%

ISRG Ownership

Ownership
Inst Owners88.66%
Ins Owners0.45%
Short Float %2.07%
Short Ratio2.92